Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Shehab

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
The American Journal of Case Reports|November 12, 2021
Tofacitinib for a Child with Refractory Steroid-Dependent Ulcerative Colitis: A Case Report and Review of the LiteratureRefaa Alajmi, Munirah Alabdulhadi, Ali A Alali, et al.
The American Journal of Case Reports|July 19, 2021
A Rare Cause of Chronic Liver Disease Diagnosed by Endoscopic Ultrasound-Guided Liver BiopsyNourah A Alajeel, Mohammad Shehab, Issam Francis, et al.
Journal of Diabetes Science and Technology|April 29, 2024
Accuracy and Feasibility of Using a Smartphone Application for Carbohydrate Counting Versus Traditional Carbohydrate Counting for Adults With Insulin-Treated DiabetesMohammad Shehab, Robert M Cohen, Bonnie Brehm, et al.
BMJ Open Gastroenterology|March 5, 2021
Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysisMohammad Shehab, Fatema Alrashed, Sameera Shuaibi, et al.
Inflammatory Bowel Diseases|May 23, 2022
Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsMohammad Shehab, Fatema Alrashed, Valérie Heron, et al.
BMJ Open Gastroenterology|November 2, 2021
Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysisFatema Alrashed, Robert Battat, Israa Abdullah, et al.
Expert Opinion on Biological Therapy|July 24, 2024
The potential for medical therapies to address fistulizing Crohn's disease: a state-of-the-art reviewMohammad Shehab, Davide De Marco, Peter L Lakatos, et al.
Frontiers in Medicine|October 18, 2021
Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel DiseaseIsraa Abdullah, Ghadeer Alhendi, Anwar Alhadab, et al.
The Journal of Physical Chemistry. B|October 9, 2007
Modified calix[4]pyrrole receptor: solution thermodynamics of anion complexation and a preliminary account on the phosphate extraction ability of its oligomerAngela F Danil de Namor, Mohammad Shehab, Rasha Khalife, et al.
Expert Review of Gastroenterology & Hepatology|March 24, 2023
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trialsMohammad Shehab, Fatema Alrashed, Afrah Alkazemi, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
The American Journal of Case Reports|November 12, 2021
Tofacitinib for a Child with Refractory Steroid-Dependent Ulcerative Colitis: A Case Report and Review of the LiteratureRefaa Alajmi, Munirah Alabdulhadi, Ali A Alali, et al.
The American Journal of Case Reports|July 19, 2021
A Rare Cause of Chronic Liver Disease Diagnosed by Endoscopic Ultrasound-Guided Liver BiopsyNourah A Alajeel, Mohammad Shehab, Issam Francis, et al.
Journal of Diabetes Science and Technology|April 29, 2024
Accuracy and Feasibility of Using a Smartphone Application for Carbohydrate Counting Versus Traditional Carbohydrate Counting for Adults With Insulin-Treated DiabetesMohammad Shehab, Robert M Cohen, Bonnie Brehm, et al.
BMJ Open Gastroenterology|March 5, 2021
Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysisMohammad Shehab, Fatema Alrashed, Sameera Shuaibi, et al.
Inflammatory Bowel Diseases|May 23, 2022
Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsMohammad Shehab, Fatema Alrashed, Valérie Heron, et al.
BMJ Open Gastroenterology|November 2, 2021
Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysisFatema Alrashed, Robert Battat, Israa Abdullah, et al.
Expert Opinion on Biological Therapy|July 24, 2024
The potential for medical therapies to address fistulizing Crohn's disease: a state-of-the-art reviewMohammad Shehab, Davide De Marco, Peter L Lakatos, et al.
Frontiers in Medicine|October 18, 2021
Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel DiseaseIsraa Abdullah, Ghadeer Alhendi, Anwar Alhadab, et al.
The Journal of Physical Chemistry. B|October 9, 2007
Modified calix[4]pyrrole receptor: solution thermodynamics of anion complexation and a preliminary account on the phosphate extraction ability of its oligomerAngela F Danil de Namor, Mohammad Shehab, Rasha Khalife, et al.
Expert Review of Gastroenterology & Hepatology|March 24, 2023
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trialsMohammad Shehab, Fatema Alrashed, Afrah Alkazemi, et al.
Pageof 7